Avidity Biosciences Inc. (RNA) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Avidity Biosciences Inc.

NASDAQ: RNA · Real-Time Price · USD
46.97
2.79 (6.32%)
At close: Oct 03, 2025, 3:59 PM
48.30
2.84%
After-hours: Oct 03, 2025, 07:56 PM EDT

Avidity Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
219.87M 185.08M 340.4M 320.45M
Short-Term Investments
1.28B 410.27M 270.33M 85.09M
Long-Term Investments
n/a n/a 251K 251K
Other Long-Term Assets
3.32M 596K 598K 599K
Receivables
28.22M 1.1M 2.36M 900K
Inventory
n/a n/a n/a -900K
Other Current Assets
n/a 7.52M 1.51M n/a
Total Current Assets
1.54B 611.31M 622.94M 411.14M
Property-Plant & Equipment
18.29M 16.65M 15.01M 15.59M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
21.61M 17.25M 15.86M 16.44M
Total Assets
1.56B 628.55M 638.8M 427.58M
Account Payables
8.46M 8.81M 4.64M 2.81M
Deferred Revenue
20.99M 28.36M 5.04M 4.86M
Short-Term Debt
n/a n/a n/a 1.77M
Other Current Liabilities
3.66M n/a n/a -1.77M
Total Current Liabilities
98.02M 80.68M 51.91M 29.66M
Long-Term Debt
n/a 6.21M 7.58M 9.96M
Other Long-Term Liabilities
n/a -6.21M -7.58M n/a
Total Long-Term Liabilities
40.92M 47.11M 8.82M 16.49M
Total Liabilities
138.94M 127.79M 60.73M 46.15M
Total Debt
6.8M 9.85M 10.69M 11.73M
Book Value
1.42B 500.76M 578.08M 381.43M
Book Value Per Share
12.77 6.86 11.08 9.21
Common Stock
12K 8K 7K 5K
Retained Earnings
-893.07M -570.76M -358.54M -184.55M
Comprehensive Income
2.9M 125K -2.7M -187K
Shareholders Equity
1.42B 500.76M 578.08M 381.43M
Total Investments
1.28B 410.27M 270.33M 85.09M